Nivolumab and/or Ipilimumab With or Without Azacitidine in Treating Patients With Myelodysplastic Syndrome
Clinical trial NCT02530463 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02530463
- Sponsor
- M.D. Anderson Cancer Center
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-08
- Primary completion
- 2027-09-30
- Enrollment
- 99
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.